At present, patients with facial hormone-dependent dermatitis in China mainly come from two groups of people: long-term topical use of glucocorticoid-containing drugs and long-term topical use of glucocorticoid-containing cosmetic skin care products, and most of them are “dependent” due to incorrect use of cosmetic skin care products, and such patients often think they are These patients often think they are “skin allergic” and come to the clinic. When asking for medical history, it is impossible to find out the “history of topical hormone medication”, and it is not easy for patients to accept the diagnosis of “hormone dependent dermatitis”. This is because it is difficult to detect the presence of certain glucocorticoids in the cosmetics used by the patient through laboratory tests. Patients often have a very unpleasant facial triad: pronounced dryness, pronounced itching, and pronounced burning, with chronic recurrent episodes that improve with topical glucocorticoids or oral or injectable glucocorticoids, and with “suspected hormone-containing cosmetic skin care products”, but can reappear as soon as they stop using them for 3-5 days. “These patients can basically be diagnosed as facial hormone dependent dermatitis. Before treatment, we should have good communication with the patient: we should let the patient fully understand that this is a kind of “hormone dependent dermatitis”, and to quit the “dependence symptoms”, we must stop using the previous drugs or skin care products and use hormone-free moisturizing skin care products externally, but generally there will be However, there is usually a rebound period of 2-4 weeks for the “trichotillomania”, otherwise the patient may think that the moisturizer prescribed by the doctor is ineffective and may even think that the skin care products have allergic reactions. Of course, patients with facial glucocorticoid-dependent dermatitis can take oral medications such as hydroxychloroquine, doxycycline, antihistamines, and topical cold compresses or astringent and antipruritic medication masks. After 1-2 months of treatment, after the uncomfortable symptoms have basically subsided, patients can stop using medications and continue to consolidate treatment with topical moisturizing skin care products. For some patients with stubborn facial hormone dependent dermatitis, immunosuppressants such as tacrolimus or pimecrolimus cream can be used topically, together with moisturizing skin care products. When the symptoms are basically controlled, the immunosuppressants will be gradually stopped, but moisturizing skin care products will continue to be used. So moisturizing skin care is throughout the whole process of facial glucocorticoid-dependent dermatitis treatment.